Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05389930

Cannabis' Impact on Alcohol Consumption

Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
Brown University · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.

Detailed description

This study employs a repeated measures experimental design to examine the effect of THC-dominant (9.53% THC and 0.09% CBD) dose of cannabis and CBD-dominant (0.35% THC and 11.27% CBD) dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly to obtain the final sample of 200 with complete data. Participants will be tested at a baseline session, during three experimental sessions, and then during a subsequent 4-week period in the natural environment using a smart-phone application. Findings have important implications for cannabis regulatory science and alcohol use disorder treatment by addressing the relative impact of specific cannabinoids as well as contextual risk in cannabis-alcohol co-use.

Conditions

Interventions

TypeNameDescription
DRUGTHC-dominant cannabisSmoked cannabis with 9.53% THC and 0.09% CBD
DRUGCBD-dominant cannabisSmoked cannabis with 0.35% THC and 11.27% CBD
DRUGCannabis placeboSmoked placebo cannabis plant material
DRUGAlcoholDrink containing 0.3 g/kg of alcohol
DRUGAlcohol placeboPlacebo beverage contains only juice and a negligible trace of alcohol for masking

Timeline

Start date
2023-03-16
Primary completion
2027-03-31
Completion
2027-03-31
First posted
2022-05-25
Last updated
2024-08-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05389930. Inclusion in this directory is not an endorsement.